Lazuna, Merlina .
HRN: 24-05-52 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2024
CEFUROXIME 1.5GM (VIAL)
10/25/2024
10/26/2024
IV
1.5g
Ptor
Prophylaxis
Waiting Final Action
10/26/2024
CEFOTAXIME 500MG (VIAL)
10/26/2024
11/02/2024
ORAL
500mg
BID
S/P D&C
Waiting Final Action